Clinical trial / 2008
Flaxseed lignan extract improved lower urinary tract symptoms in benign prostatic hyperplasia.
In a randomized, double-blind, placebo-controlled trial, 87 subjects with benign prostatic hyperplasia were assigned to 0, 300, or 600 mg/day of secoisolariciresinol diglucoside for 4 months (78 completed). International Prostate Symptom Scores decreased by -3.67 +/- 1.56 (P = .100), -7.33 +/- 1.18 (P < .001), and -6.88 +/- 1.43 (P < .001) compared to baseline. Quality of life scores improved by -0.71 +/- 0.23, -1.48 +/- 0.24, and -1.75 +/- 0.25 (P = .103, < .001, and < .001 vs. baseline; P = .163 and .012 vs. placebo). Maximum urinary flow increases and postvoiding urine volume decreases did not reach statistical significance.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 87 subjects with benign prostatic hyperplasia
- What was measured
- Lower urinary tract symptoms, quality of life scores, and urinary parameters
THE PAPER
Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia.
Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, Sun SZ. J Med Food, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.